Top

Abdominal Radiology

Published in:

01-06-2016 | Invited Article

Cystic renal masses

Author: Nicole M. Hindman

Published in: Abdominal Radiology | Issue 6/2016

Abstract

Purpose

The purpose of the study is to provide an update on the imaging evaluation of cystic renal masses, to review benign and malignant etiologies of cystic renal masses, and to review current controversies and future directions in the management of these lesions.

Conclusions

Cystic renal masses are relatively common in daily practice. The Bosniak classification is a time-proven method for the imaging classification and management of these lesions. Knowledge of the pathognomonic features of certain benign Bosniak 2F/3 lesions is important to avoid surgery on these lesions (e.g., localized cystic disease, renal abscess). For traditionally surgical Bosniak lesions (Classes 3 and 4), there are evolving data that risk stratification based on patient demographics, imaging size, and appearance may allow for expanded management options including tailored surveillance or ablation, along with the traditional surgical approach.

Corica FA, Iczkowski KA, Cheng L, et al. (1999) Cystic renal cell carcinoma is cured by resection: a study of 24 cases with long-term followup. J Urol 161(2):408–411PubMedCrossRef

Huber J, Winkler A, Jakobi H, et al. (2014) Preoperative decision making for renal cell carcinoma: cystic morphology in cross-sectional imaging might predict lower malignant potential. Urol Oncol 32(1):37.e31–37.e36. doi:10.1016/j.urolonc.2013.02.016 CrossRef

Park HS, Lee K, Moon KC (2011) Determination of the cutoff value of the proportion of cystic change for prognostic stratification of clear cell renal cell carcinoma. J Urol 186(2):423–429. doi:10.1016/j.juro.2011.03.107 PubMedCrossRef

Silverman SG, Israel GM, Herts BR, Richie JP (2008) Management of the incidental renal mass. Radiology 249(1):16–31. doi:10.1148/radiol.2491070783 PubMedCrossRef

Carrim ZI, Murchison JT (2003) The prevalence of simple renal and hepatic cysts detected by spiral computed tomography. Clin Radiol 58(8):626–629PubMedCrossRef

O’Connor SD, Silverman SG, Ip IK, Maehara CK, Khorasani R (2013) Simple cyst-appearing renal masses at unenhanced CT: Can they be presumed to be benign? Radiology 269(3):793–800. doi:10.1148/radiol.13122633 PubMedCrossRef

Bosniak MA (1986) The current radiological approach to renal cysts. Radiology 158(1):1–10. doi:10.1148/radiology.158.1.3510019 PubMedCrossRef

Cloix P, Martin X, Pangaud C, et al. (1996) Surgical management of complex renal cysts: a series of 32 cases. J Urol 156(1):28–30PubMedCrossRef

Curry NS, Cochran ST, Bissada NK (2000) Cystic renal masses: accurate Bosniak classification requires adequate renal CT. Am J Roentgenol 175(2):339–342CrossRef

10.

Levy P, Helenon O, Merran S, et al. (1999) Cystic tumors of the kidney in adults: radio-histopathologic correlations. J radiol 80(2):121–133PubMed

11.

Graumann O, Osther SS, Karstoft J, Horlyck A, Osther PJ (2015) Bosniak classification system: a prospective comparison of CT, contrast-enhanced US, and MR for categorizing complex renal cystic masses. Acta radiol . doi:10.1177/0284185115588124

12.

Warren KS, McFarlane J (2005) The Bosniak classification of renal cystic masses. BJU Int 95(7):939–942. doi:10.1111/j.1464-410X.2005.05442.x PubMedCrossRef

13.

Koga S, Nishikido M, Inuzuka S, et al. (2000) An evaluation of Bosniak’s radiological classification of cystic renal masses. BJU Int 86(6):607–609PubMedCrossRef

14.

Silverman SG, Israel GM, Trinh QD (2015) Incompletely characterized incidental renal masses: emerging data support conservative management. Radiology 275(1):28–42. doi:10.1148/radiol.14141144 PubMedCrossRef

15.

Harisinghani MG, Maher MM, Gervais DA, et al. (2003) Incidence of malignancy in complex cystic renal masses (Bosniak category III): Should imaging-guided biopsy precede surgery? Am J Roentgenol 180(3):755–758CrossRef

16.

Hindman NM, Hecht EM, Bosniak MA (2014) Follow-up for Bosniak category 2F cystic renal lesions. Radiology 272(3):757–766. doi:10.1148/radiol.14122908 PubMedCrossRef

17.

O’Malley RL, Godoy G, Hecht EM, Stifelman MD, Taneja SS (2009) Bosniak category IIF designation and surgery for complex renal cysts. J Urol 182(3):1091–1095. doi:10.1016/j.juro.2009.05.046 PubMedCrossRef

18.

Smith AD, Allen BC, Sanyal R, et al. (2015) Outcomes and complications related to the management of Bosniak cystic renal lesions. Am J Roentgenol 204(5):W550–W556. doi:10.2214/AJR.14.13149 CrossRef

19.

Smith AD, Remer EM, Cox KL, et al. (2012) Bosniak category IIF and III cystic renal lesions: outcomes and associations. Radiology 262(1):152–160. doi:10.1148/radiol.11110888 PubMedCrossRef

20.

Hollenbeck BK, Taub DA, Miller DC, Dunn RL, Wei JT (2006) Use of nephrectomy at select medical centers—a case of follow the crowd? J Urol 175(2):670–674. doi:10.1016/S0022-5347(05)00146-1 PubMedCrossRef

21.

Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK (2006) Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98(18):1331–1334. doi:10.1093/jnci/djj362 PubMedCrossRef

22.

Howlader N, Noone A, Krapcho M, et al. (eds) (2013) SEER cancer statistics review, 1975–2011. Bethesda: National Cancer Institute

23.

Hartman DS, Davis CJ Jr, Johns T, Goldman SM (1986) Cystic renal cell carcinoma. Urology 28(2):145–153PubMedCrossRef

24.

Moch H (2010) Cystic renal tumors: new entities and novel concepts. Adv Anat Pathol 17(3):209–214. doi:10.1097/PAP.0b013e3181d98c9d PubMedCrossRef

25.

Han KR, Janzen NK, McWhorter VC, et al. (2004) Cystic renal cell carcinoma: biology and clinical behavior. Urol Oncol 22(5):410–414. doi:10.1016/S1078-1439(03)00173-X PubMedCrossRef

26.

Hindman NM, Bosniak MA, Rosenkrantz AB, Lee-Felker S, Melamed J (2012) Multilocular cystic renal cell carcinoma: comparison of imaging and pathologic findings. Am J Roentgenol 198(1):W20–W26. doi:10.2214/AJR.11.6762 CrossRef

27.

Koga S, Nishikido M, Hayashi T, et al. (2000) Outcome of surgery in cystic renal cell carcinoma. Urology 56(1):67–70PubMedCrossRef

28.

Winters BR, Gore JL, Holt SK, et al. (2015) Cystic renal cell carcinoma carries an excellent prognosis regardless of tumor size. Urol Oncol 33(12):505.e509–505.e513. doi:10.1016/j.urolonc.2015.07.017 CrossRef

29.

Kouba E, Smith A, McRackan D, Wallen EM, Pruthi RS (2007) Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention. J Urol 177(2):466–470; discussion 470. doi:10.1016/j.juro.2006.09.064

30.

Rendon RA, Stanietzky N, Panzarella T, et al. (2000) The natural history of small renal masses. J Urol 164(4):1143–1147PubMedCrossRef

31.

Shuch B, Hanley JM, Lai JC, et al. (2014) Adverse health outcomes associated with surgical management of the small renal mass. J Urol 191(2):301–308. doi:10.1016/j.juro.2013.08.074 PubMedCrossRef

32.

Shinagare AB, Vikram R, Jaffe C, et al. (2015) Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research Group. Abdom Imaging 40(6):1684–1692. doi:10.1007/s00261-015-0386-z PubMedCrossRef

33.

Pedrosa I, Chou MT, Ngo L, et al. (2008) MR classification of renal masses with pathologic correlation. Eur Radiol 18(2):365–375. doi:10.1007/s00330-007-0757-0 PubMedCrossRef

34.

Italiano A (2011) Prognostic or predictive? It’s time to get back to definitions! J Clin Oncol Off J Am Soc Clin Oncol 29(35):4718; author reply 4718–4719. doi:10.1200/JCO.2011.38.3729

35.

Kuo MD, Jamshidi N (2014) Behind the numbers: decoding molecular phenotypes with radiogenomics-guiding principles and technical considerations. Radiology 270(2):320–325. doi:10.1148/radiol.13132195 PubMedCrossRef

36.

Doshi AM, Huang WC, Donin NM, Chandarana H (2015) MRI features of renal cell carcinoma that predict favorable clinicopathologic outcomes. Am J Roentgenol 204(4):798–803. doi:10.2214/AJR.14.13227 CrossRef

37.

Kang SK, Zhang A, Pandharipande PV, et al. (2015) DWI for renal mass characterization: systematic review and meta-analysis of diagnostic test performance. Am J Roentgenol 205(2):317–324. doi:10.2214/AJR.14.13930 CrossRef

38.

Israel GM, Bosniak MA (2005) How I do it: evaluating renal masses. Radiology 236(2):441–450. doi:10.1148/radiol.2362040218 PubMedCrossRef

39.

Israel GM, Bosniak MA (2004) MR imaging of cystic renal masses. Magn Reson Imaging Clin N Am 12(3):403–412, v. doi:10.1016/j.mric.2004.03.006

40.

Bosniak MA (2012) The Bosniak renal cyst classification: 25 years later. Radiology 262(3):781–785. doi:10.1148/radiol.11111595 PubMedCrossRef

41.

Israel GM, Bosniak MA (2005) An update of the Bosniak renal cyst classification system. Urology 66(3):484–488. doi:10.1016/j.urology.2005.04.003 PubMedCrossRef

42.

Birnbaum BA, Hindman N, Lee J, Babb JS (2007) Renal cyst pseudoenhancement: influence of multidetector CT reconstruction algorithm and scanner type in phantom model. Radiology 244(3):767–775. doi:10.1148/radiol.2443061537 PubMedCrossRef

43.

Mileto A, Nelson RC, Marin D, Choudhury KR, Ho LM (2014) Dual-energy multidetector CT for the characterization of incidental adrenal nodules: diagnostic performance of contrast-enhanced material density analysis. Radiology. doi:10.1148/radiol.14140876

44.

Israel GM, Hindman N, Bosniak MA (2004) Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system. Radiology 231(2):365–371. doi:10.1148/radiol.2312031025 PubMedCrossRef

45.

Balci NC, Semelka RC, Patt RH, et al. (1999) Complex renal cysts: findings on MR imaging. Am J Roentgenol 172(6):1495–1500. doi:10.2214/ajr.172.6.10350279 CrossRef

46.

Hecht EM, Israel GM, Krinsky GA, et al. (2004) Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Radiology 232(2):373–378. doi:10.1148/radiol.2322031209 PubMedCrossRef

47.

Kim S, Jain M, Harris AB, et al. (2009) T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging. Radiology 251(3):796–807. doi:10.1148/radiol.2513080724 PubMedCrossRef

48.

Heverhagen JT (2007) Noise measurement and estimation in MR imaging experiments. Radiology 245(3):638–639. doi:10.1148/radiol.2453062151 PubMedCrossRef

49.

Rosenkrantz AB, Wehrli NE, Mussi TC, Taneja SS, Triolo MJ (2014) Complex cystic renal masses: comparison of cyst complexity and Bosniak classification between 1.5 T and 3 T MRI. Eur J Radiol 83(3):503–508. doi:10.1016/j.ejrad.2013.11.013 PubMedCrossRef

50.

Chandarana H, Block TK, Rosenkrantz AB, et al. (2011) Free-breathing radial 3D fat-suppressed T1-weighted gradient echo sequence: a viable alternative for contrast-enhanced liver imaging in patients unable to suspend respiration. Investig Radiol 46(10):648–653. doi:10.1097/RLI.0b013e31821eea45 CrossRef

51.

Rosenkrantz AB, Niver BE, Fitzgerald EF, et al. (2010) Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. Am J Roentgenol 195(5):W344–W351. doi:10.2214/AJR.10.4688 CrossRef

52.

Chandarana H, Kang SK, Wong S, et al. (2012) Diffusion-weighted intravoxel incoherent motion imaging of renal tumors with histopathologic correlation. Investig Radiol 47(12):688–696. doi:10.1097/RLI.0b013e31826a0a49 CrossRef

53.

Squillaci E, Manenti G, Di Stefano F, et al. (2004) Diffusion-weighted MR imaging in the evaluation of renal tumours. J Exp Clin Cancer Res 23(1):39–45PubMed

54.

Zhang J, Tehrani YM, Wang L, et al. (2008) Renal masses: characterization with diffusion-weighted MR imaging—a preliminary experience. Radiology 247(2):458–464. doi:10.1148/radiol.2472070823 PubMedCrossRef

55.

Jamis-Dow CA, Choyke PL, Jennings SB, et al. (1996) Small (< or =3-cm) renal masses: detection with CT versus US and pathologic correlation. Radiology 198(3):785–788. doi:10.1148/radiology.198.3.8628872 PubMedCrossRef

56.

Bosniak MA (1991) Difficulties in classifying cystic lesions of the kidney. Urol Radiol 13(2):91–93PubMedCrossRef

57.

Chang YW, Kwon KH, Goo DE, et al. (2007) Sonographic differentiation of benign and malignant cystic lesions of the breast. J Ultrasound Med 26(1):47–53PubMed

58.

Ascenti G, Mazziotti S, Zimbaro G, et al. (2007) Complex cystic renal masses: characterization with contrast-enhanced US. Radiology 243(1):158–165. doi:10.1148/radiol.2431051924 PubMedCrossRef

59.

Clevert DA, Minaifar N, Weckbach S, et al. (2008) Multislice computed tomography versus contrast-enhanced ultrasound in evaluation of complex cystic renal masses using the Bosniak classification system. Clin Hemorheol Microcirc 39(1–4):171–178PubMed

60.

Ignee A, Straub B, Brix D, et al. (2010) The value of contrast enhanced ultrasound (CEUS) in the characterisation of patients with renal masses. Clin Hemorheol Microcirc 46(4):275–290. doi:10.3233/CH-2010-1352 PubMed

61.

Park BK, Kim B, Kim SH, et al. (2007) Assessment of cystic renal masses based on Bosniak classification: comparison of CT and contrast-enhanced US. Eur J Radiol 61(2):310–314. doi:10.1016/j.ejrad.2006.10.004 PubMedCrossRef

62.

Chawla SN, Crispen PL, Hanlon AL, et al. (2006) The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175(2):425–431. doi:10.1016/S0022-5347(05)00148-5 PubMedCrossRef

63.

Hollenbeck BK, Taub DA, Miller DC, Dunn RL, Wei JT (2006) National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology 67(2):254–259. doi:10.1016/j.urology.2005.08.050 PubMedCrossRef

64.

Webster WS, Thompson RH, Cheville JC, et al. (2007) Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma. Urology 70(5):900–904; discussion 904. doi:10.1016/j.urology.2007.05.029

65.

Berland LL, Silverman SG, Gore RM, et al. (2010) Managing incidental findings on abdominal CT: White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol 7(10):754–773. doi:10.1016/j.jacr.2010.06.013 PubMedCrossRef

66.

Thompson RH, Hill JR, Babayev Y, et al. (2009) Metastatic renal cell carcinoma risk according to tumor size. J Urol 182(1):41–45. doi:10.1016/j.juro.2009.02.128 PubMedPubMedCentralCrossRef

67.

Volpe A, Panzarella T, Rendon RA, et al. (2004) The natural history of incidentally detected small renal masses. Cancer 100(4):738–745. doi:10.1002/cncr.20025 PubMedCrossRef

68.

Hindman NM (2015) Approach to very small (< 1.5 cm) cystic renal lesions: ignore, observe, or treat? Am J Roentgenol 204(6):1182–1189. doi:10.2214/AJR.15.14357 CrossRef

69.

Horikawa M, Shinmoto H, Kuroda K, et al. (2012) Mixed epithelial and stromal tumor of the kidney with polypoid component extending into renal pelvis and ureter. Acta radiol Short Rep. doi:10.1258/arsr.2011.110010 PubMedPubMedCentral

70.

Wood CG III, Stromberg LJ III, Harmath CB, et al. (2015) CT and MR imaging for evaluation of cystic renal lesions and diseases. Radiogr Rev Publ Radiol Soc N Am 35(1):125–141. doi:10.1148/rg.351130016

71.

Jevremovic D, Lager DJ, Lewin M (2006) Cystic nephroma (multilocular cyst) and mixed epithelial and stromal tumor of the kidney: a spectrum of the same entity? Ann Diagn Pathol 10(2):77–82. doi:10.1016/j.anndiagpath.2005.07.011 PubMedCrossRef

72.

Turbiner J, Amin MB, Humphrey PA, et al. (2007) Cystic nephroma and mixed epithelial and stromal tumor of kidney: a detailed clinicopathologic analysis of 34 cases and proposal for renal epithelial and stromal tumor (REST) as a unifying term. Am J Surg Pathol 31(4):489–500. doi:10.1097/PAS.0b013e31802bdd56 PubMedCrossRef

73.

Chowdhury AR, Chakraborty D, Bhattacharya P, Dey RK (2013) Multilocular cystic renal cell carcinoma a diagnostic dilemma: a case report in a 30-year-old woman. Urol Ann 5(2):119–121. doi:10.4103/0974-7796.110012 PubMedPubMedCentralCrossRef

74.

Imura J, Ichikawa K, Takeda J, et al. (2004) Multilocular cystic renal cell carcinoma: a clinicopathological, immuno- and lectin histochemical study of nine cases. Acta pathol microbiol immunol Scand 112(3):183–191. doi:10.1111/j.1600-0463.2004.apm1120304.x CrossRef

75.

Brinker DA, Amin MB, de Peralta-Venturina M, et al. (2000) Extensively necrotic cystic renal cell carcinoma: a clinicopathologic study with comparison to other cystic and necrotic renal cancers. Am J Surg Pathol 24(7):988–995PubMedCrossRef

76.

Williamson SR, Eble JN, Cheng L, Grignon DJ (2013) Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile. Mod Pathol 26(5):697–708. doi:10.1038/modpathol.2012.204 PubMedCrossRef

77.

Srigley JR, Delahunt B, Eble JN, et al. (2013) The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia. Am J Surg Pathol 37(10):1469–1489. doi:10.1097/PAS.0b013e318299f2d1 PubMedCrossRef

78.

MacLennan GT, Farrow GM, Bostwick DG (1997) Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin. Urology 50(5):679–684. doi:10.1016/S0090-4295(97)00335-X PubMedCrossRef

79.

Halat S, Eble JN, Grignon DJ, et al. (2010) Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma. Mod Pathol 23(7):931–936. doi:10.1038/modpathol.2010.78 PubMedCrossRef

80.

Allory Y, Ouazana D, Boucher E, Thiounn N, Vieillefond A (2003) Papillary renal cell carcinoma. Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases. Virchows Arch Int J Pathol 442(4):336–342. doi:10.1007/s00428-003-0787-1

81.

Bielsa O, Lloreta J, Gelabert-Mas A (1998) Cystic renal cell carcinoma: pathological features, survival and implications for treatment. Br J Urol 82(1):16–20PubMedCrossRef

82.

Pierorazio PM, Hyams ES, Tsai S, et al. (2013) Multiphasic enhancement patterns of small renal masses (</=4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma. Urology 81(6):1265–1271. doi:10.1016/j.urology.2012.12.049 PubMedPubMedCentralCrossRef

83.

Young JR, Margolis D, Sauk S, et al. (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology 267(2):444–453. doi:10.1148/radiol.13112617 PubMedCrossRef

84.

Karlo CA, Di Paolo PL, Chaim J, et al. (2014) Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations. Radiology 270(2):464–471. doi:10.1148/radiol.13130663 PubMedPubMedCentralCrossRef

85.

Goenka AH, Remer EM, Smith AD, et al. (2013) Development of a clinical prediction model for assessment of malignancy risk in Bosniak III renal lesions. Urology 82(3):630–635. doi:10.1016/j.urology.2013.05.016 PubMedCrossRef

86.

Silverman SG, Gan YU, Mortele KJ, Tuncali K, Cibas ES (2006) Renal masses in the adult patient: the role of percutaneous biopsy. Radiology 240(1):6–22. doi:10.1148/radiol.2401050061 PubMedCrossRef

87.

Mues AC, Haramis G, Badani K, et al. (2010) Active surveillance for larger (cT1bN0M0 and cT2N0M0) renal cortical neoplasms. Urology 76(3):620–623. doi:10.1016/j.urology.2010.04.021 PubMedCrossRef

88.

Haramis G, Mues AC, Rosales JC, et al. (2011) Natural history of renal cortical neoplasms during active surveillance with follow-up longer than 5 years. Urology 77(4):787–791. doi:10.1016/j.urology.2010.09.031 PubMedCrossRef

89.

Hwang JH, Lee CK, Yu HS, et al. (2012) Clinical outcomes of Bosniak category IIF complex renal cysts in Korean patients. Korean J Urol 53(6):386–390. doi:10.4111/kju.2012.53.6.386 PubMedPubMedCentralCrossRef

90.

Israel GM, Bosniak MA (2003) Follow-up CT of moderately complex cystic lesions of the kidney (Bosniak category IIF). Am J Roentgenol 181(3):627–633. doi:10.2214/ajr.181.3.1810627 CrossRef

91.

Jhaveri K, Gupta P, Elmi A, et al. (2013) Cystic renal cell carcinomas: Do they grow, metastasize, or recur? Am J Roentgenol 201(2):W292–W296. doi:10.2214/AJR.12.9414 CrossRef

92.

Carrafiello G, Dionigi G, Ierardi AM, et al. (2013) Efficacy, safety and effectiveness of image-guided percutaneous microwave ablation in cystic renal lesions Bosniak III or IV after 24 months follow up. Int J Surg 11(Suppl 1):S30–S35. doi:10.1016/S1743-9191(13)60010-2 PubMedCrossRef

93.

Felker ER, Lee-Felker SA, Alpern L, Lu D, Raman SS (2013) Efficacy of imaging-guided percutaneous radiofrequency ablation for the treatment of biopsy-proven malignant cystic renal masses. Am J Roentgenol 201(5):1029–1035. doi:10.2214/AJR.12.10210 CrossRef

Title: Cystic renal masses
Author: Nicole M. Hindman
Publication date: 01-06-2016
Publisher: Springer US
Published in: Abdominal Radiology / Issue 6/2016
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-016-0761-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2016

Effect of available intravenous access on accuracy and timeliness of epinephrine administration

CT negative attenuation pixel distribution and texture analysis for detection of fat in small angiomyolipoma on unenhanced CT

MR urography in children and adolescents: techniques and clinical applications

The “beak” sign

Inherited renal carcinomas

Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage